Altogether, these results suggested that impaired ATP production and neurodevelopment induced by CNNM2-rs1926032 genotype-dependent ATP5MD downregulation might increase susceptibility to schizophrenia. The gene discussed is ATP5MK; the disease is schizophrenia.